Company: NGVT
Filing Date: 2025-02-19
Form Type: 10-K
Source: 0001653477-25-000015
Chunk: 122

Company: Ingevity Corp
Filing Date: 2025-02-19
Form: 10-K
Item: Item 4
Chunk 122
---
31, 2024, 2023, and 2022

Goodwill impairment charge of $349.1 million for the year ended December 31, 2024 within our Performance Chemicals reporting unit. See Note 8 for more information.

Acquisition-related costs

Years Ended December 31, 2024, 2023, and 2022 

Acquisition costs were $0.3 million, $3.6 million, and $5.0 million for the years ended December 31, 2024, 2023, and 2022, respectively. For the twelve months ended December 31, 2024, 2023, and 2022, all charges related to the integration of Ozark Materials into our Performance Chemicals segment. See Note 16 for more information.

Other (income) expense, net

Years Ended December 31, 2024, 2023, and 2022

 Years Ended December 31,In millions202420232022(Gain) loss on strategic investments (1)$11.4 $(19.3)$— Foreign currency transaction (gain) loss4.2 3.7 2.3 CEO severance charges4.8 — — Loss on CTO resales (2)52.7 22.0 — CTO supply contract termination charges (2)100.0 — — Other (income) expense, net(3.3)(0.7)(4.0)Total Other (income) expense, net$169.8 $5.7 $(1.7)

_______________

(1) See Note 5 for more information.

(2) See Note 15 for more information.

33

Interest expense

Years Ended December 31, 2024, 2023, and 2022

Years Ended December 31,In millions202420232022  Finance lease obligations (1)$7.3 $7.3 $7.5   Revolving credit facility and term loan (2) (3)57.2 59.1 21.2   Senior Notes (3)22.4 22.4 33.1 Accounts receivable securitization (3)5.7 1.5 —   Litigation related interest expense (4)5.2 3.0 — Total interest expense$97.8